Literature DB >> 17066460

A prospective study of admissions for febrile neutropenia in secondary paediatric units in South East England.

C Duncan1, J C Chisholm, S Freeman, U Riley, M Sharland, K Pritchard-Jones.   

Abstract

BACKGROUND: The Paediatric Oncology Centres (POCs) treating childhood cancer in South East England produce unified supportive care guidelines for use in the secondary pediatric (shared care) units. This study evaluated the adherence to current guidelines for febrile neutropenia (FN) and documented outcome in terms of bacterial isolates, antibiotic resistance patterns, length of hospital stay, and mortality. PROCEDURE: Prospective study of pediatric FN admissions between July 2001 and December 2002.
RESULTS: Data were received on 433 eligible FN episodes in 212 patients. The recommended empirical antibiotics (piptazobactam + gentamicin) were used in 354 (82%) admissions. Blood cultures were positive in 129 episodes (30%). Gram-positive organisms predominated (120/149 organisms isolated) and the majority were coagulase-negative Staphylococci (95/120). There were 27 Gram-negative isolates and 1 fungal isolate. No Gram-negative isolate was resistant to both first-line antibiotics. Only one death was recorded in the study group. The median length of hospital stay was 5 days.
CONCLUSIONS: We obtained data on a large number of shared care episodes of FN. The antibiotic guidelines were followed in most episodes. Bacteremia was common, but little resistance to first-line antibiotics was documented among Gram-negative isolates, confirming the safety of the strategy in our population. (c) 2007 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17066460     DOI: 10.1002/pbc.21041

Source DB:  PubMed          Journal:  Pediatr Blood Cancer        ISSN: 1545-5009            Impact factor:   3.167


  8 in total

1.  Evaluation of six risk factors for the development of bacteremia in children with cancer and febrile neutropenia.

Authors:  E J Asturias; J E Corral; J Quezada
Journal:  Curr Oncol       Date:  2010-04       Impact factor: 3.677

2.  Outpatient management of febrile neutropenia in children with cancer.

Authors:  Ottavio Ziino; Fabio Tucci; Mario Renato Rossi
Journal:  Pediatr Rep       Date:  2011-02-24

3.  Bacterial bloodstream infections and antimicrobial susceptibility pattern in pediatric hematology/oncology patients after anticancer chemotherapy.

Authors:  Naima A Al-Mulla; Saad J Taj-Aldeen; Sittana El Shafie; Mohammed Janahi; Abdullah A Al-Nasser; Prem Chandra
Journal:  Infect Drug Resist       Date:  2014-11-06       Impact factor: 4.003

4.  Individual participant data validation of the PICNICC prediction model for febrile neutropenia.

Authors:  Bob Phillips; Jessica Elizabeth Morgan; Gabrielle M Haeusler; Richard D Riley
Journal:  Arch Dis Child       Date:  2019-11-05       Impact factor: 3.791

Review 5.  Optimising Antimicrobial Selection and Duration in the Treatment of Febrile Neutropenia in Children.

Authors:  Jessica E Morgan; Bob Phillips; Gabrielle M Haeusler; Julia C Chisholm
Journal:  Infect Drug Resist       Date:  2021-03-30       Impact factor: 4.003

6.  Alarming Antibiotic Resistance in Pediatric Oncology Patients: A Three-Year Prospective Cohort Study from Oman.

Authors:  Abeer Al Battashi; Bishara Al Harrassi; Nawal Al Maskari; Hilal Al Hashami; Salah Al Awaidy
Journal:  Infect Drug Resist       Date:  2022-07-25       Impact factor: 4.177

Review 7.  Predicting infectious complications in neutropenic children and young people with cancer (IPD protocol).

Authors:  Robert S Phillips; Alex J Sutton; Richard D Riley; Julia C Chisholm; Susan V Picton; Lesley A Stewart
Journal:  Syst Rev       Date:  2012-02-09

8.  Episodes of fever in neutropenia in pediatric patients with cancer in Bern, Switzerland, 1993-2012.

Authors:  Maxime G Zermatten; Christa Koenig; Annina von Allmen; Philipp Agyeman; Roland A Ammann
Journal:  Sci Data       Date:  2019-01-15       Impact factor: 6.444

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.